Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

CAD & Atherosclerosis

  • Article

    Rivaroxaban Monotherapy is Preferable to Combination Therapy with Antiplatelets with Regards to Total Cardiovascular and Bleeding Events in Patients with AF and Stable CAD

    January 3, 2023

    Dr. Clemo Clinical question: Is there a difference in total thrombotic and/or bleeding events in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) on rivaroxaban...

  • Article

    DES reduce the risk of ISR in patients with ICAS compared to BMS

    August 1, 2022

    Dr. Snipe Clinical question: In patients with symptomatic high-grade intracranial atherosclerotic stenosis (ICAS), does the use of a drug-eluting stent (DES) reduce the incidence of in-stent...

  • 1
    News

    Empagliflozin a winner in challenging arena of stabilized acute HF

    November 19, 2021

    Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.

  • 1
    News

    Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT

    November 17, 2021

    The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.

  • News

    Cardiogenic shock teams again tied to lower mortality

    September 23, 2021

    New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.

  • News

    Growing proportion of cardiac arrests in U.S. considered opioid related

    September 10, 2021

    Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.

  • News

    Docs fight back after losing hospital privileges, patients, and income

    August 10, 2021

    Physicians in St. Louis lost their hospital privileges when the hospital entered into an exclusive contract with other physicians. They’re losing patients and money.

  • 1
    News

    ESC heart failure guideline to integrate bounty of new meds

    July 29, 2021

    It has a simple answer to a seemingly complex issue: how to merge the newly approved with mainstay drug therapies. And it conditionally okays meds in a group long without guideline-directed options.

  • 1
    News

    Statins again linked to lower COVID-19 mortality

    July 21, 2021

    Patients hospitalized for COVID-19 who had been taking statins had a substantially lower risk of death and severe outcomes than those who weren’t in a large observational study.

  • News

    Simple risk assessment predicts post-PCI ischemic events

    June 15, 2021

    Determining if PCI patients have just one or more guideline-based risk features predicts their odds of ischemic events, and can be used to tailor antiplatelet therapy, suggests a real-world analysis.

1 2 3 … 5Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences